Revolution Beauty Group, the mass beauty and personal care business behind brands such as REVOLUTION and Makeup Revolution, has spent recent years working through a difficult restructuring. The company returned its co-founders to leadership, cut costs, and exited non-core brands and products after a period of heavy losses. Its fiscal year runs from March to February, making the six months ended 31 August 2026 the first half of fiscal 2027. Because this interim report marks the first half-year period in which the group generated positive adjusted EBITDA, it serves as an important checkpoint on whether the turnaround is genuinely translating into sustainable profitability rather than simply narrower losses.
For the six months ended 31 August 2026, Revolution Beauty reported adjusted EBITDA of £2.0 million, a swing from the £12.5 million loss recorded in the same period a year earlier. Revenue came in at £48.4 million, down about 2% on a headline basis, reflecting the removal of discontinued brands, prior-year clearance activity, and one-off license income. Excluding those items, underlying revenue grew 8.3%.
Gross margin improved materially to 43.6% from 32.2%, helped by the absence of clearance sales, lower gross-to-net charges, and tighter inventory and range management. Operating costs fell roughly 33% to £19.1 million, and the loss before tax narrowed to £1.9 million from £18.4 million. Reported loss per share was GBX 0.20.
Online sales across the company's own website, TikTok Shop, and Amazon rose 22%, driven primarily by TikTok Shop. Net debt declined to £25.7 million from £30.2 million a year earlier, with cash of £4.3 million. Management said September and October trading was in line with expectations and guided toward the top end of full-year market forecasts. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Investor reaction to the interim results was mixed. The shares had rallied strongly in the run-up to the announcement, and the market's focus remained on forward momentum rather than the historical figures. The confirmation of a return to positive adjusted EBITDA, a sharp gross margin improvement, and online sales growth were seen as evidence that the turnaround is progressing. However, the disclosure of a material uncertainty over going concern tempered enthusiasm, highlighting that the group could breach financing covenants in a severe downside scenario unless further mitigating actions succeed. This balance between improving operational trends and lingering balance-sheet risk has kept sentiment cautious even as management described trading as comfortably ahead of expectations.
Management enters the seasonally stronger second half with several growth levers in motion. The company's licensing partnership with Debenhams Group — covering fragrance and gifting under the PrettyLittleThing, Karen Millen, and boohooMAN brands — is expected to launch its first collections ahead of Christmas. Retailer order books are showing early signs of a positive response to range changes, and online channels remain a forward indicator of demand.
Investors will be watching whether gross margin holds in the low-to-mid 40% range, whether the 22% online growth led by TikTok Shop proves sustainable, and whether US and international revenue stabilize after recent declines. The festive trading period represents the next major test of demand.
Balance-sheet resilience remains a central theme. Net debt has fallen, but the going-concern uncertainty means covenant headroom, working capital management, and the outcome of ongoing commercial matters and claims will be closely monitored. The company expects full-year revenue of £92.0 million to £95.0 million and adjusted EBITDA of £6.0 million to £6.6 million, positioning the second half as the decisive period for confirming a durable return to profitable growth. From what I see, ongoing monitoring of these factors will be key for REVB.
In my own research, I find Tickeron’s AI Screener particularly useful for quickly identifying comparable turnaround candidates across consumer sectors. It streamlines the process of filtering by fundamentals and trends, helping me cross-check ideas like this one without spending hours on manual screens.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
REVB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 46 of 53 cases where REVB's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 87%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where REVB's RSI Oscillator exited the oversold zone, 38 of 48 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for REVB just turned positive on October 30, 2026. Looking at past instances where REVB's MACD turned positive, the stock continued to rise in 32 of 38 cases over the following month. The odds of a continued upward trend are 84%.
Following a +12.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where REVB advanced for three days, in 144 of 179 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 28 of 29 cases where REVB's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on REVB as a result. In 76 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where REVB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for REVB entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.535) is normal, around the industry mean (2.788). P/E Ratio (0.144) is within average values for comparable stocks, (-0.376). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.911) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. REVB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. REVB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Biotechnology